We are live on
!
Find out more
PCM
Pavaki Capital Management Portfolio holdings
AUM
$287M
This Fund
S&P 500
This Quarter
Est. Return
+12.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow
% of AUM
54.05%
Top 10 Holdings %
Top 10 Hldgs %
57.32%
Holding
131
New
131
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Milestone Pharmaceuticals
MIST
|
+$18.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$13.2M |
| 3 |
ARS Pharmaceuticals
SPRY
|
+$11.4M |
| 4 |
B
Barrick Mining
B
|
+$7.28M |
| 5 |
Walt Disney
DIS
|
+$6.72M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.5% |
| 2 | Healthcare | 29.54% |
| 3 | Materials | 10.85% |
| 4 | Communication Services | 4.97% |
| 5 | Technology | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CALL
Salesforce
CRM
$185B
| $2.12M | 0.83% |
+8,000
| New | +$1.99M |
|
27
Ligand Pharmaceuticals
LGND
$6.19B
| $2.1M | 0.82% |
+11,100
| New | +$2.13M |
|
28
Bio-Rad Laboratories Class A
BIO
$10.1B
| $1.82M | 0.71% |
+6,000
| New | +$1.87M |
|
29
CALL
O'Reilly Automotive
ORLY
$69.6B
| $1.75M | 0.69% |
+19,200
| New | +$1.88M |
|
30
Royalty Pharma
RPRX
$25.9B
| $1.7M | 0.67% |
+44,000
| New | +$1.68M |
|
31
Baidu
BIDU
$29.5B
| $1.7M | 0.67% |
+13,000
| New | +$1.61M |
|
32
CALL
AutoZone
AZO
$46.5B
| $1.7M | 0.66% |
+500
| New | +$1.89M |
|
33
SSR Mining
SSRM
$6.92B
| $1.64M | 0.64% |
+75,000
| New | +$1.67M |
|
|
34
PUT
O'Reilly Automotive
ORLY
$69.6B
| $1.61M | 0.63% |
+17,600
| New | +$1.72M |
|
35
PUT
Palantir
PLTR
$449B
| $1.6M | 0.63% |
+9,000
| New | +$1.63M |
|
36
Yum China
YUMC
$13.8B
| $1.43M | 0.56% |
+30,000
| New | +$1.37M |
|
37
Equinox Gold
EQX
$13.3B
| $1.4M | 0.55% |
+100,000
| New | +$1.26M |
|
38
Kinross Gold
KGC
$28.8B
| $1.39M | 0.55% |
+49,500
| New | +$1.29M |
|
39
PUT
Toll Brothers
TOL
$12.5B
| $1.35M | 0.53% |
+10,000
| New | +$1.36M |
|
40
Syndax Pharmaceuticals
SNDX
$1.63B
| $1.26M | 0.49% |
+60,000
| New | +$1.05M |
|
41
CALL
Oracle
ORCL
$418B
| $1.17M | 0.46% |
+6,000
| New | +$1.43M |
|
42
Sphere Entertainment
SPHR
$4.82B
| $1.13M | 0.44% |
+11,860
| New | +$904K |
|
43
Hewlett Packard
HPE
$81.6B
| $985K | 0.39% |
+41,000
| New | +$966K |
|
44
CALL
SAP
SAP
$243B
| $972K | 0.38% |
+4,000
| New | +$1.02M |
|
45
Sanofi
SNY
$97.6B
| $969K | 0.38% |
+20,000
| New | +$991K |
|
46
Roivant Sciences
ROIV
$26.4B
| $868K | 0.34% |
+40,000
| New | +$789K |
|
47
Advanced Micro Devices
AMD
$992B
| $857K | 0.34% |
+4,000
| New | +$898K |
|
48
CALL
McDonald's
MCD
$166B
| $856K | 0.34% |
+2,800
| New | +$858K |
|
49
Royal Gold
RGLD
$20.2B
| $834K | 0.33% |
+3,750
| New | +$744K |
|
50
Banco Bradesco
BBD
$35.6B
| $814K | 0.32% |
+244,336
| New | +$831K |
|
Similar funds
OCM
RSC
MC
QFW
SRWM
ORC
MPAM
AWMT
Pavaki Capital Management's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Pavaki Capital Management, which disclosed 131 positions worth $255M. Its ten largest holdings account for 57% of the portfolio.
Its largest position is Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, followed by Healthcare and Materials.
- Pavaki Capital Management's largest Q4 2025 buy was Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
- Pavaki Capital Management's ten largest holdings make up 57% of its $255M portfolio in Q4 2025.
- Pavaki Capital Management disclosed 131 positions in Q4 2025, its first 13F filing on record.
Based on Pavaki Capital Management's 13F filing for Q4 2025, filed 7 Aug 2026.